Palisade Bio (PALI)
Develops a once-daily oral PDE4 prodrug for ulcerative colitis and Crohn's disease.
$2.04
Pre-market+0.04 (+2.26%)
At close$2.00(+1.79%)
Something off on this page? Send us feedback.
Next report
Nov 9, 2026
estimated · in 67 days
EPS estimate
−$0.06
Revenue estimate
$465.3K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.69−$0.47−$0.58−$0.38−$0.04−$0.05−$0.05Pending
Estimate−$1.99−$0.84−$0.48−$0.32−$0.02−$0.04−$0.05−$0.06
Surprise+65.3%+44.0%−20.8%−18.8%−100.0%−25.0%+4.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$4.0K—————$500.0KPending
Estimate——————$500.0K$465.3K
Surprise——————0.0%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.06 | — | — |
| Aug 2026 | −$0.05 | −$0.05 | +4.3% |
| May 2026 | −$0.04 | −$0.05 | −25.0% |
| Mar 2026 | −$0.02 | −$0.04 | −100.0% |
| Nov 2025 | −$0.32 | −$0.38 | −18.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$0.06 | — | — | $465.3K | — | — | — |
| Aug 10, 2026 | −$0.05 | −$0.05 | +4.3% | $500.0K | $500.0K | 0.0% | +1.9% |
| May 12, 2026 | −$0.04 | −$0.05 | −25.0% | — | — | — | −2.6% |
| Mar 23, 2026 | −$0.02 | −$0.04 | −100.0% | — | — | — | +4.7% |
| Nov 10, 2025 | −$0.32 | −$0.38 | −18.8% | — | — | — | +2.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 11, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 26, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 22, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 13, 2022 | |||||||
| Mar 16, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 24, 2021 | |||||||
| May 14, 2021 | |||||||
| Mar 22, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 15, 2020 | |||||||
| Mar 27, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 14, 2019 | |||||||
| Mar 22, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 13, 2018 | |||||||
| May 15, 2018 | |||||||
| Apr 2, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 23, 2017 | |||||||
| Nov 8, 2016 | |||||||
| Aug 11, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 14, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 10, 2015 | |||||||